Search

Balu D Palani

from Cupertino, CA
Age ~71
Get Report
Also known as:
Palani B Balu, Palani Maragadham Balu, Palani Te Balu, Palani Balasubramanian, Balasubramanian Palani, Dalani Balu, Palaniappan Balasubramanian, Balasubramanian Palaniappan
Related to:
Vimal R Balu, 33Mara Asubramanian, 66Vidhya Balasubramanian, 39
Connected to:
Geetha Palani, 45Lingeshwaran Palaniappan, 45Mani Palaniappan, 44Meenakshi Palaniappan, 35Raghavan Palaniappan, 54Rajeswari Palaniappan, 46Rajkumar Palaniappan, 53Srinivasan Palaniappan, 50Thomas S Palanica, 72Vijay V Palaniappan, 42

Balu Palani Phones & Addresses

  • Cupertino, CA
  • Pittsford, NY

Publications

Us Patents

Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
7414105, Aug 19, 2008
Filed:
Oct 27, 2005
Appl. No.:
11/261157
Inventors:
Christopher P. Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - Sunnyvale CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - Santa Clara CA, US
Assignee:
Affymax, Inc. - Palo Alto CA
International Classification:
A01N 43/40
A61K 38/00
US Classification:
530323, 514 9, 930 90
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
7528104, May 5, 2009
Filed:
May 12, 2004
Appl. No.:
10/555868
Inventors:
Christopher P. Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - Sunnyvale CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - Santa Clara CA, US
Assignee:
Affymax, Inc. - Palo Alto CA
International Classification:
A01N 43/40
A61K 38/00
US Classification:
514 2, 514 12, 514 13, 514 14, 530323, 530324, 530326, 530327, 5303882, 530402
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
8304391, Nov 6, 2012
Filed:
Mar 17, 2009
Appl. No.:
12/405599
Inventors:
Christopher P. Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - San Diego CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - San Jose CA, US
Assignee:
Affymax, Inc. - Palo Alto CA
International Classification:
A61K 38/16
A61K 38/19
US Classification:
514 214, 514 79, 514 134, 514 135, 514 213
Abstract:
Peptide compounds that are agonists of the erythropoietin receptor (EPO-R) are described, as well as therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Novel Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
20050137329, Jun 23, 2005
Filed:
May 12, 2004
Appl. No.:
10/844968
Inventors:
Christopher Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter Schatz - Cupertino CA, US
David Tumelty - Sunnyvale CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - Santa Clara CA, US
Assignee:
Affymax, Inc. - Palo Alto CA
International Classification:
A61K038/12
C08G063/48
C08G063/91
US Classification:
525054100, 530317000, 424078300, 514009000
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Novel Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
20090048166, Feb 19, 2009
Filed:
Jul 11, 2008
Appl. No.:
12/171610
Inventors:
Christopher P. Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - San Diego CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - San Jose CA, US
Assignee:
AFFYMAX, INC. - Palo Alto CA
International Classification:
A61K 38/16
C07K 14/00
US Classification:
514 12, 530323
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Novel Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
20110245176, Oct 6, 2011
Filed:
Nov 12, 2010
Appl. No.:
12/945687
Inventors:
Christopher P. Holmes - Saratoga CA, US
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - San Diego CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - San Jose CA, US
Assignee:
AFFYMAX, INC. - Palo Alto CA
International Classification:
A61K 38/16
C07K 14/00
A61P 7/06
A61P 35/00
US Classification:
514 135, 530324, 514 213, 514 18, 514 192
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
20130130979, May 23, 2013
Filed:
Oct 18, 2012
Appl. No.:
13/654507
Inventors:
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - San Diego CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - San Jose CA, US
Assignee:
AFFYMAX, INC. - Palo Alto CA
International Classification:
A61K 38/16
A61K 38/10
US Classification:
514 77, 514 135
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

Novel Peptides That Bind To The Erythropoietin Receptor

View page
US Patent:
20130244939, Sep 19, 2013
Filed:
Nov 1, 2012
Appl. No.:
13/666579
Inventors:
Qun Yin - Palo Alto CA, US
Guy Lalonde - Woodside CA, US
Peter J. Schatz - Cupertino CA, US
David Tumelty - San Diego CA, US
Balu Palani - Cupertino CA, US
Genet Zemede - San Jose CA, US
Assignee:
AFFYMAX, INC. - Palo Alto CA
International Classification:
C07K 14/00
C07K 7/08
US Classification:
514 135
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Control profile
Balu D Palani from Cupertino, CA, age ~71 Get Report